Screening for Syphilis Infection During Pregnancy
JAMA · 10.06.2025 · 333 (22) · 2006
DOI: 10.1001/jama.2025.5009 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 10.06.2025. Verfasst von US Preventive Services Task Force und 17 weiteren Autor:innen. Beteiligte Einrichtung: Brown University, Providence, Rhode Island. Hauptthemen laut MEDLINE: Mass Screening, Pregnancy Complications, Infectious, Syphilis, Syphilis, Congenital. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones, anemia, enlarged liver and spleen, jaundice, brain and nerve problems (eg, permanent vision or hearing loss), and meningitis. In 2023, there were 3882 cases of congenital syphilis in the US, including 279 congenital syphilis–related stillbirths and neonatal/infant deaths, the highest number reported in more than 30 years. Objective The US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update focused on the benefits and harms of screening for syphilis infection in pregnancy. Population Adolescents and adults who are pregnant. Evidence Assessment The USPSTF concludes with high certainty that screening for syphilis infection in pregnancy has a substantial net benefit. Recommendation The USPSTF recommends early, universal screening for syphilis infection during pregnancy; if an individual is not screened early in pregnancy, the USPSTF recommends screening at the first available opportunity. (A recommendation)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Brown University, Providence, Rhode Island.
- Tufts University School of Medicine, Boston, Massachusetts.
- University of Maryland School of Medicine, Baltimore.
- Virginia Commonwealth University, Richmond.
- University of Washington, Seattle.
- University of California, San Francisco.
Förderung
- NIA NIH HHS
Zitieren
APA
US Preventive Services Task Force, Silverstein, M., Wong, J. B., Davis, E. M., Chelmow, D., Coker, T. R., Fernandez, A., Gibson, E., Jaén, C. R., Krousel-Wood, M., Lee, S., Nicholson, W. K., Rao, G., Ruiz, J. M., Stevermer, J., Tsevat, J., Underwood, S. M., & Wiehe, S. (2025). Screening for Syphilis Infection During Pregnancy. JAMA, 333(22), 2006. https://doi.org/10.1001/jama.2025.5009
Vancouver
US Preventive Services Task Force, Silverstein M, Wong JB, Davis EM, Chelmow D, Coker TR, et al. Screening for Syphilis Infection During Pregnancy. JAMA. 2025;333(22):2006. doi:10.1001/jama.2025.5009
BibTeX
@article{USPreventiveServicesTaskForce2025,
author = {US Preventive Services Task Force, US Preventive Services Task Force and Silverstein, Michael and Wong, John B and Davis, Esa M and Chelmow, David and Coker, Tumaini Rucker and Fernandez, Alicia and Gibson, Ericka and Jaén, Carlos Roberto and Krousel-Wood, Marie and Lee, Sei and Nicholson, Wanda K and Rao, Goutham and Ruiz, John M and Stevermer, James and Tsevat, Joel and Underwood, Sandra Millon and Wiehe, Sarah},
title = {Screening for Syphilis Infection During Pregnancy},
journal = {JAMA},
year = {2025},
volume = {333},
number = {22},
pages = {2006},
doi = {10.1001/jama.2025.5009}
}
EUVIMED